Scott M. Lippman, M.D.: Short CV

More documents

Recommendations

Info

$Week 05\G, A and R 02.pdf$

Curriculum Vitae Scott M. Lippman, M.D. Page 6 HONORS AND AWARDS Dean's Honor List and Special Honors in Research, UCI, 1974-1977 Phi Beta Kappa, UCI, 1977 Magna Cum Laude, UCI, 1977 Jayne M. Unzelman Scholarship Academic Excellence and Service, UCI, 1977 NIH Student Grant "Autoimmune Hematologic Disorders," 1980 Teaching Award, American Academy of Family Physicians, 1987 Travel Award, ASCO, 1988 American Cancer Society Career Development Award, 1989-1992 ACS 32 nd /36 th Science Writers’ Award, 1990, 1994 Margaret and Ben Love Professorship in Clinical Cancer Care in Honor of Dr. Charles A. LeMaistre, 1997-2001 The Faculty Achievement Award, Cancer Prevention, 1998 The Best Doctors in America, 1998– Who’s Who (Marquis and Strathmore), 2000 Anderson Clinical Faculty Chair for Cancer Treatment and Research, 2001-2004 Ellen F. Knisely Distinguished Chair in Colon Cancer Research, 2004– RESEARCH Grants and Contracts Funded, active Principal Investigator, Selenium, Vitamin E Cancer Prevention Trial; SELECT Study Coordinator Chair, Southwest Oncology Group, S/C 6U10 CA037429, SELECT-04001, 09/27/99-05/31/06, $55,650 (annual direct). Principal Investigator, Southwest Oncology Group Cancer Control Committee, Southwest Oncology Group, S/C 5 U10 CA037429, CCOP-04000, 12/96- 05/31/05, $76,268 (annual direct)
Curriculum Vitae Scott M. Lippman, M.D. Page 7 Principal Investigator, Selenium Based Chemoprevention HGPIN, Southwest Oncology Group, 1 U01 CA077178, SELENIUM-03003, 07/01/98-07/31/05, $6,809 (annual direct) Co-Investigator, The Impact of Smoking on Lung Cancer Chemoprevention – PP- 1 - Clinical Trial of Celecoxib in Lung Cancer Chemoprevention, National Cancer Institute, 5 P01 CA091844 (PP-1), 08/20/01-07/31/06, $319,623 (annual direct) Co-Investigator, Biochemoprevention Therapy in Advanced Laryngeal Dysplasia, National Cancer Institute, 5 U01 CA079437, 09/01/98-06/30/05, $319,070 (annual direct) Principal Investigator, Phase I Pharmacodynamic Study of COX-2 Inhibition and Aromatase Activity in Breast Cancer, National Cancer Institute, RFP: N01-CN- 35112, 02/18/03-02/17/06, $424,730 (annual direct) Program Leader, Cancer Center Support (CORE) Grant – PP-7 - Clinical Cancer Prevention Program, National Cancer Institute, 5 P30 CA016672, 07/01/03- 06/30/08, $20,443 (annual direct) Principal Investigator, Phase 1 and 2 Clinical Trials of Cancer Chemopreventive Agents, National Cancer Institute, N01-CN-35159, 09/30/03-09/29/06, $1,274,192 (annual direct) Principal Investigator, U10 Full Member Application Affiliated with SWOG, National Cancer Institute, 1 U10 CA105409, 07/26/04-12/31/09, $198,381 (annual direct) Principal Investigator, Molecular-Based Therapy for Oral Cancer Prevention, National Cancer Institute, 1 P01 CA106451, 08/01/04-07/31/09, $1,370,095 (annual direct) Principal Investigator, Biology of the Prostate Cancer Prevention Trial (PCPT), 1 P01 CA108964-01A1, 05/01/05-04/30/10, $2,429,913 (annual direct) Completed (previous year) Co-Investigator, Biology and Chemoprevention of Head and Neck Cancer – PP-1 - Chemoprevention Trial to Prevent Second Primary Tumors with Low-Dose 13cis Retinoic Acid in Head and Neck Cancer, National Cancer Institute, 5 P01 CA052051 (PP-1), 08/05/91-11/30/04.
Page 1 and 2: NAME: Scott M. Lippman, M.D. CURRIC
Page 3 and 4: Curriculum Vitae Scott M. Lippman,
Page 5: Curriculum Vitae Scott M. Lippman,
Page 57 and 58:
Curriculum Vitae Scott M. Lippman,
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
show all

Scott M. Lippman, M.D.: Short CV

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?